Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study.
Diabetes, obesity & metabolism（2023）
Abstract
These results support the benefits of semaglutide in a real-world setting in adults with T2D in France showing a significant reduction in HbA1c and body weight.
MoreTranslated text
Key words
antidiabetic drug,glycaemic control,observational study,real-world evidence,semaglutide,weight control
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined